「Real-world efficacy of adalimumab and infliximab for refractory intestinal Behçet's disease<Abstract of dissertation>」の関連論文
-
Morphea in a Crohn's disease patient undergoing ustekinumab treatment
-
Occurrence of cholangiocarcinoma, three years after negative seroconversion of anti-TIF1γ antibody, in a dermatomyositis patient
-
Efficacy and Safety of Adalimumab Therapy for the Treatment of Non-infectious Uveitis: Efficacy comparison among Uveitis Aetiologies
-
Efficacy and Safety of Adalimumab Therapy for the Treatment of Non-infectious Uveitis: Efficacy comparison among Uveitis Aetiologies
-
Association of CD4-positive cell infiltration with response to vedolizumab in patients with ulcerative colitis
-
Autoantibodies against the plakin family proteins as a novel marker for chronic graft-versus-host disease of the lung
-
A case of systemic lupus erythematosus/systemic sclerosis overlap syndrome successfully treated with belimumab
-
Glucocorticoid in Combination with a TNF-α Inhibitor: Treatment of Deep Vein Thrombosis in a Patient with Behçet's Disease
-
Results of the guideline-based treatment for pemphigus : a single-centre experience with 84 cases (本文)
-
Analysis of immunologic comorbidities in ulcerative colitis patients: a tool to prevent exacerbations in ulcerative colitis cases
-
Immune checkpoint inhibitors for patients with pre-existing autoimmune diseases
-
Multidisciplinary diagnostic approach for fulminant myocarditis related to coronavirus disease 2019 messenger RNA vaccines: a case report
-
Paraneoplastic Pemphigus Mimicking Toxic Epidermal Necrolysis Associated with Follicular Lymphoma: Possible Pathological Role of CD8 T Cells.
-
Phase 3 Trial of Concizumab in Hemophilia with Inhibitors
-
A case of chronic eosinophilic pneumonia associated with rheumatoid arthritis in glucocorticoid-free remission with JAK inhibitor: A case report
-
The impact of contour maps on estimating the risk of gastrointestinal stromal tumor recurrence: indications for adjuvant therapy: an analysis of the Kinki GIST registry
-
Usefulness of interleukin-18 as a diagnostic biomarker to differentiate adult-onset Still’s disease with/without macrophage activation syndrome from other secondary hemophagocytic lymphohistiocytosis in adults
-
Expression of urokinase-type plasminogen activator system in non-metastatic prostate cancer
-
Delayed immune-related sclerosing cholangitis after discontinuation of pembrolizumab: A case report
-
Effectiveness of surgery and hyperbaric oxygen for antiresorptive agent-related osteonecrosis of the jaw: A subgroup analysis by disease stage
-
Combined Hypophysitis and Type 1 Diabetes Mellitus Related to Immune Checkpoint Inhibitors
-
A study of pathophysiological roles of immune system-related receptors that regulate intestinal mucosal barrier function in inflammatory bowel disease model
-
Identification of an Anti-Integrin αvβ6 Autoantibody in Patients With Ulcerative Colitis
-
Clinical Significance of Serum Galectin-9 and Soluble CD155 Levels in Patients with Systemic Sclerosis
-
転移性尿路上皮癌に対するGC療法における, Gemcitabine投与後の発熱の臨床的意義の検討: 多施設共同後ろ向き研究
-
Lenvatinib-induced severe generalized erythematous rash in a patient with hepatocellular carcinoma
-
Chronic cystoisosporiasis in an immunocompetent adult : A case report.
-
MYC Upregulation Is a Useful Biomarker for Preoperative Neoadjuvant Chemotherapy Combined With Anti-EGFR in Liver Metastasis from Colorectal Cancer
-
セツキシマブ併用放射線治療中にニューモシスチス肺炎を発症し,診断に苦慮した1例
-
Rituximab in combination with cyclosporine and steroid pulse therapy for childhood-onset multidrug-resistant nephrotic syndrome: a multicenter single-arm clinical trial (JSKDC11 trial)
-
Janus Kinase Inhibitors Ameliorated Gastrointestinal Amyloidosis and Hypoalbuminemia in Persistent Dermatitis Mouse Model
-
The clinical significance of CXCL16 in the treatment of advanced non-small cell lung cancer
-
Cutaneous T-cell-attracting chemokine as a novel biomarker for predicting prognosis of idiopathic pulmonary fibrosis: a prospective observational study
-
Suppression of Systemic Lupus Erythematosus in NZBWF1 mice infected with Hymenolepis microstoma
-
Survival impact of treatment for chronic obstructive pulmonary disease in patients with advanced non-small-cell lung cancer
-
Efficacy of local therapy for oligoprogressive disease after programmed cell death 1 blockade in advanced non-small cell lung cancer
-
Increased expression of programmed cell death ligand 1 and galectin 9 in transplant recipients who achieved tolerance after immunosuppression withdrawal
-
The fruits of CD40 research in basic and clinical medicine will soon be harvested
-
Metformin enhances the antitumor activity of oncolytic herpes simplex virus HF10 (canerpaturev) in a pancreatic cell cancer subcutaneous model
-
Systemic therapy for salivary gland malignancy: current status and future perspectives
-
Targeting AURKA in treatment of peritoneal tumor dissemination in gastrointestinal cancer (本文)
-
Relative hypercoagulation induced by suppressed fibrinolysis after tisagenlecleucel infusion in malignant lymphoma
-
Third-look endoscopy prevents delayed bleeding after endoscopic submucosal dissection under antithrombotic therapy
-
Survival Analyses Based on Tumor Microenvironment Profile in Endometrial Carcinoma
-
In situ vaccination using unique TLR9 ligand K3-SPG induces long-lasting systemic immune response and synergizes with systemic and local immunotherapy
-
Genetic and chemical inhibition of IRF5 suppresses pre-existing mouse lupus-like disease
-
Effectiveness of Profiling Serum IL-18 and Neopterin in Diagnosis of Adult-Onset Still's Disease Complicated by Pulmonary Tuberculosis: A Case Report
-
Aseptic meningitis as an initial presentation of Sjögren syndrome: a report of two cases and literature review
-
The lectin-like domain of thrombomodulin is a drug candidate for both prophylaxis and treatment of liver ischemia and reperfusion injury in mice
-
Evaluation and Prediction of Treatment Response for Hepatocellular Carcinoma